Dyne Therapeutics, Inc.
DYNNASDAQHealthcare● Active
$16.81
$-0.23(-1.35%)
Market Cap$2.8B
P/E Ratio—
52W High$25
52W Low$8.06
Dyne Therapeutics, Inc.（DYN）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · DYN · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.45B) | ($0.32B) | ($0.24B) | ($0.17B) | ($0.15B) |
| Depreciation & Amort. | $0.00B | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.05B | $0.05B | $0.02B | $0.02B | $0.02B |
| Change in Working Capital | ($0.00B) | ($0.02B) | $0.03B | ($0.01B) | $0.01B |
| Net Cash from Operations | ($0.40B) | ($0.29B) | ($0.19B) | ($0.15B) | ($0.12B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.18B) | ($0.32B) | ($0.04B) | ($0.12B) | ($0.24B) |
| Sales of Investments | $0.17B | $0.12B | $0.13B | $0.21B | $0.10B |
| Net Cash from Investing | ($0.03B) | ($0.20B) | $0.08B | $0.09B | ($0.14B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.15B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.89B | $0.81B | $0.05B | $0.04B | $0.16B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.41B) | ($0.29B) | ($0.19B) | ($0.16B) | ($0.12B) |
| FCF Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Dyne Therapeutics, Inc.
关于Dyne Therapeutics, Inc.（DYN）现金流量表
Dyne Therapeutics, Inc. 2025财年经营活动现金流($0.40B)，自由现金流($0.41B)（FCF利润率—），资本支出($0.00B)。
常见问题
DYN · 4 问Dyne Therapeutics, Inc. 2025财年自由现金流($0.41B)，同比down37.4%。
DYN free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10